FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 03/16/2020 |
3. Issuer Name and Ticker or Trading Symbol
Sensata Technologies Holding plc [ ST ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Ordinary Shares, par value EUR 0.01 per share | 27,632(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock options to Buy | (2) | 01/28/2023 | Ordinary Shares, par value EUR 0.01 per share | 5,050(3) | $34.74 | D | |
Stock options to Buy | (2) | 04/01/2024 | Ordinary Shares, par value EUR 0.01 per share | 8,748(4) | $43.16 | D | |
Stock options to Buy | (2) | 04/01/2025 | Ordinary Shares, par value EUR 0.01 per share | 4,816(5) | $56.94 | D | |
Stock options to Buy | (6) | 04/01/2026 | Ordinary Shares, par value EUR 0.01 per share | 8,496(7) | $38.96 | D | |
Stock options to Buy | (8) | 04/01/2027 | Ordinary Shares, par value EUR 0.01 per share | 10,863(9) | $43.67 | D | |
Stock options to Buy | (10) | 04/01/2028 | Ordinary Shares, par value EUR 0.01 per share | 9,380(11) | $51.83 | D | |
Stock options to Buy | (12) | 04/01/2029 | Ordinary Shares, par value EUR 0.01 per share | 11,862(13) | $46.93 | D |
Explanation of Responses: |
1. Includes unvested performance-based restricted securities granted to the reporting person on various dates as follows: 6,442 granted on April 1, 2017; 5,307 granted on April 1, 2018 and 6,446 granted on April 1, 2019. These restricted securities will vest three years after their respective grant date subject to the issuer's satisfaction of certain performance criteria. Also includes unvested time-based restricted securities granted to the reporting person on various dates as follows: 1,546 granted on April 1, 2017; 1,448 granted on April 1, 2018; 1,758 granted on April 1, 2019 and 4,685 granted on June 1, 2019. These restricted securities will vest three years after their respective grant date. |
2. These options are currently exercisable. |
3. Consists of options granted to the reporting person on January 28, 2013. |
4. Consists of options granted to the reporting person on April 1, 2014. |
5. Consists of options granted to the reporting person on April 1, 2015. |
6. These options are exercisable over four years at 25% per year, beginning on the first anniversary date of the grant. Currently, 6,372 of these options are exercisable. |
7. Consists of options granted to the reporting person on April 1, 2016. |
8. These options are exercisable over four years at 25% per year, beginning on the first anniversary date of the grant. Currently, 5,431 of these options are exercisable. |
9. Consists of options granted to the reporting person on April 1, 2017. |
10. These options are exercisable over four years at 25% per year, beginning on the first anniversary date of the grant. Currently, 2,345 of these options are exercisable. |
11. Consists of options granted to the reporting person on April 1, 2018. |
12. These options are exercisable over four years at 25% per year, beginning on the first anniversary date of the grant. None of these options are exercisable. |
13. Consists of options granted to the reporting person on April 1, 2019. |
Remarks: |
/s/ Michael Richards by power of attorney | 03/26/2020 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |